| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |